Skip to main content

Revelation Biosciences, Inc. (REVB)

Sector
Healthcare
Industry
Biotechnology
Last price
$3.88
As of

Kresmion compiles this page from REVB's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.

REVELATION BIOSCIENCES, INC. (REVB): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-11-13.

As of . Source: SEC EDGAR filings for REVB. Method and limitations.

COMPANY DOSSIER

See the full REVB dossier

Price with insider and filing markers, who is positioning, fundamentals and peers for REVB on one page. Preview it with sample data, then open it live with a free account.

Preview the REVB dossier

Active events for REVB

  • mediumEarnings above estimates

    Q3-2026: Beat consensus by 5.8%, EPS $-5.92 vs $-6.2832 estimate

  • medium13F: new position

    CITADEL ADVISORS LLC new position in REVB

  • mediumEarnings below estimates

    Q1-2026: Missed consensus by 131.0% - EPS $-2.71 vs $-1.173 estimate

  • mediumEarnings below estimates

    Q2-2025: Missed consensus by 54.3% - EPS $-28.04 vs $-18.1764 estimate

  • mediumEarnings below estimates

    Q3-2025: Missed consensus by 30.0% - EPS $-7.08 vs $-5.4468 estimate

FREE, NO ACCOUNT

Every event on REVB, as it fires

You are seeing 5 of 7 events recorded on REVB since 2026-05-26.

The five above landed across 4 days. The other 2 were recorded on those same days.

Get it by email

No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.

Join on Telegram
Join on Telegram

One tap. Live alerts, no email needed.

No non-option holdings from tracked managers in this reporting quarter. Other reporting quarters are linked above.

Recent SEC filings, REVB

Going concern statement

REVB's 10-Q filed Nov 5, 2026 states:

…which raises substantial doubt about its ability to continue as a going concern.

Read the 10-Q on SEC EDGAR Every company with a going concern statement

More data on REVB

REVB against its peers

REVB's return on equity of -100.6% ranks in the 68th percentile of 16 Biotechnology sub-industry peers, fiscal periods ending between 2025-03-31 and 2026-06-30.

MetricREVBPeer medianPercentilen
Revenue FYn/a359700n/a9
Gross marginn/a77.6%n/a9
Operating marginn/a-3270.0%n/a10
Net marginn/a-3189.7%n/a10
Return on equity-100.6%-212.6%6816
1 yearn/a-91.1%n/a14

Peers (20): VIVS, HCWB, CASIF, APVO, SLXN, PPBT, CLDI, ONCO, BRTX, ACUT, DCOY, LSBCF.D, CMND, SXTP, JUNS, SILO, EOCN, PPCB, ERNA, MBIO. Left out: AGNPF (no annual filing), GPLL (period gap), BIXT (no annual filing), VCNX (period gap), NYMXF (period gap). Fiscal periods ending between 2025-03-31 and 2026-06-30. Every figure is one full fiscal year read from one annual filing (REVB: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.

Cite this data

Kresmion counts the managers it follows that reported a non-option position in REVB on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on REVB in the last 180 days.

Upstream: SEC EDGAR filings for REVB

Kresmion, "REVELATION BIOSCIENCES, INC. (REVB) institutional holdings and SEC filings", data as of 2026-11-13, https://kresmion.com/research/REVB. Upstream data: SEC EDGAR filings for REVB.

Link to this data (HTML):

<a href="https://kresmion.com/research/REVB">REVELATION BIOSCIENCES, INC. (REVB) institutional holdings and SEC filings (Kresmion)</a>

Writing about this? Press contact and ready-to-quote figures

Follow REVB on a live board

Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to REVB for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.

Preview the REVB dossier
Share

The REVB intelligence card: the smart money composite, cross family confluence and the top current signal, with a link back to this page.